184 related articles for article (PubMed ID: 32759885)
21. Up-Regulation of MiR-1915 Inhibits Proliferation, Invasion, and Migration of
Xu XC; Zhang WB; Li CX; Gao H; Pei Q; Cao BW; He TH
Yonsei Med J; 2019 Jan; 60(1):38-47. PubMed ID: 30554489
[TBL] [Abstract][Full Text] [Related]
22. KLF5-mediated CDCA5 expression promotes tumor development and progression of epithelial ovarian carcinoma.
Chen X; Zhou M; Ma S; Wu H; Cai H
Exp Cell Res; 2023 Aug; 429(1):113645. PubMed ID: 37247719
[TBL] [Abstract][Full Text] [Related]
23. THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
Chen X; Huang Y; Wang Y; Wu Q; Hong S; Huang Z
J Physiol Biochem; 2019 Feb; 75(1):117-123. PubMed ID: 30746617
[TBL] [Abstract][Full Text] [Related]
24. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
26. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
Zeng M; Li B; Yang L; Guan Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
[TBL] [Abstract][Full Text] [Related]
27. Involvement of NEDD9 in the invasion and migration of gastric cancer.
Feng J; Zhao J; Xie H; Yin Y; Luo G; Zhang J; Feng Y; Li Z
Tumour Biol; 2015 May; 36(5):3621-8. PubMed ID: 25577245
[TBL] [Abstract][Full Text] [Related]
28. NCAPH regulates gastric cancer progression through DNA damage response.
Wang Y; Li JQ; Yang ZL; Wang L; Zhang JC; Sun YF; Li ZY; Qin L
Neoplasma; 2022 Mar; 69(2):283-291. PubMed ID: 34962823
[TBL] [Abstract][Full Text] [Related]
29. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis.
Ding Z; Lan H; Xu R; Zhou X; Pan Y
Pathol Res Pract; 2018 Dec; 214(12):1993-1999. PubMed ID: 30279010
[TBL] [Abstract][Full Text] [Related]
30. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
31. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
32. lncRNA BG981369 Inhibits Cell Proliferation, Migration, and Invasion, and Promotes Cell Apoptosis by SRY-Related High-Mobility Group Box 4 (SOX4) Signaling Pathway in Human Gastric Cancer.
Dong X; Chen R; Lin H; Lin T; Pan S
Med Sci Monit; 2018 Feb; 24():718-726. PubMed ID: 29398692
[TBL] [Abstract][Full Text] [Related]
33. MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression.
Yang D; Zhao D; Chen X
Cancer Biomark; 2017 Jul; 19(4):425-436. PubMed ID: 28582847
[TBL] [Abstract][Full Text] [Related]
34. Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma.
Huang X; Huang Y; Lv Z; Wang T; Feng H; Wang H; Du S; Wu S; Shen D; Wang C; Li H; Wang B; Ma X; Zhang X
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642672
[TBL] [Abstract][Full Text] [Related]
35. NUPR1 participates in YAP-mediate gastric cancer malignancy and drug resistance via AKT and p21 activation.
Jiang L; Wang W; Li Z; Zhao Y; Qin Z
J Pharm Pharmacol; 2021 Apr; 73(6):740-748. PubMed ID: 33793788
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.
Yao Y; Wang Y; Li L; Xiang X; Li J; Chen J; Liu Z; Huang S; Xiong J; Deng J
J Cell Mol Med; 2019 Dec; 23(12):8076-8089. PubMed ID: 31559693
[TBL] [Abstract][Full Text] [Related]
38. IL‑33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway.
Huang N; Cui X; Li W; Zhang C; Liu L; Li J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760194
[TBL] [Abstract][Full Text] [Related]
39. ESRRA promotes gastric cancer development by regulating the CDC25C/CDK1/CyclinB1 pathway via DSN1.
Li FN; Zhang QY; Li O; Liu SL; Yang ZY; Pan LJ; Zhao C; Gong W; Shu YJ; Dong P
Int J Biol Sci; 2021; 17(8):1909-1924. PubMed ID: 34131395
[No Abstract] [Full Text] [Related]
40. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
